190 related articles for article (PubMed ID: 2842263)
21. A role of red cell pyrimidine 5'-nucleotidase in experimental lead poisoning.
Fujii H
Arch Toxicol; 1979 Oct; 43(1):59-64. PubMed ID: 231420
[TBL] [Abstract][Full Text] [Related]
22. Relationship between lead concentration in blood and the activities of erythrocyte pyrimidine 5'-nucleotidase and delta-aminolevulinate dehydratase in the mice exposed to lead.
Tomokuni K; Ogata M
Arch Toxicol; 1981 Mar; 47(1):67-9. PubMed ID: 6269517
[TBL] [Abstract][Full Text] [Related]
23. Low level lead and inhibition of erythrocyte pyrimidine nucleotidase.
Angle CR; McIntire MS
Environ Res; 1978 Oct; 17(2):296-302. PubMed ID: 233817
[TBL] [Abstract][Full Text] [Related]
24. Erythrocyte nucleotides in children--increased blood lead and cytidine triphosphate.
Angle CR; McIntire MS; Swanson MS; Stohs SJ
Pediatr Res; 1982 Apr; 16(4 Pt 1):331-4. PubMed ID: 7079004
[TBL] [Abstract][Full Text] [Related]
25. Erythrocyte pyrimidine-5'-nucleotidase activity as a sensitive indicator of lead exposure.
Torrance JD; Mills W; Kilroe-Smith TA; Smith AN
S Afr Med J; 1985 May; 67(21):850-2. PubMed ID: 2986302
[TBL] [Abstract][Full Text] [Related]
26. Effect of a short, heavy exposure to lead dust upon blood lead level, erythrocyte delta-aminolevulinic acid dehydratase activity and urinary excretion of lead delta-aminolevulinic acid coproporphyrin. Results of a 6-month follow-up of two male subjects.
Schütz A; Skerfving S
Scand J Work Environ Health; 1976 Sep; 2(3):176-84. PubMed ID: 788149
[TBL] [Abstract][Full Text] [Related]
27. A case of lead intoxication: clinical and biochemical studies.
Miwa S; Ishida Y; Takegawa S; Urata G; Toyoda T
Am J Hematol; 1981; 11(1):99-105. PubMed ID: 6267939
[TBL] [Abstract][Full Text] [Related]
28. Comparative study of effects of lead on the activity of erythrocyte pyrimidine 5'-nucleotidase and delta-aminolevulinate dehydratase in vivo and in vitro.
Tomokuni K; Ogata M
Arch Toxicol; 1980 Sep; 45(3):197-201. PubMed ID: 6257208
[TBL] [Abstract][Full Text] [Related]
29. Chromatographic analysis of human erythrocyte pyrimidine 5'-nucleotidase from five patients with pyrimidine 5'-nucleotidase deficiency.
Hirono A; Fujii H; Natori H; Kurokawa I; Miwa S
Br J Haematol; 1987 Jan; 65(1):35-41. PubMed ID: 3028466
[TBL] [Abstract][Full Text] [Related]
30. Pyrimidine nucleoside monophosphate kinase hyperactivity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
Lachant NA; Zerez CR; Tanaka KR
Br J Haematol; 1987 May; 66(1):91-6. PubMed ID: 3036196
[TBL] [Abstract][Full Text] [Related]
31. Tolerance to lead-induced porphyrin metabolic disorders following lead pretreatment in mice.
Tomokuni K; Ichiba M
Toxicol Lett; 1990 Dec; 54(2-3):215-20. PubMed ID: 2260119
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of initial results of treatment of lead poisoning with EDTA].
Petkova V; Adjarov D; Pavlova S; Naydenova E; Kerimova M; Kuneva T
Med Lav; 1994; 85(4):299-308. PubMed ID: 7808345
[TBL] [Abstract][Full Text] [Related]
33. Erythrocyte pyrimidine 5'-nucleotidase and deoxynucleotidase isozymes: metallosensitivity and kinetics.
Cook L; Kubitschek C; Stohs S; Angle C
Drug Chem Toxicol; 1988 Jun; 11(2):195-213. PubMed ID: 2841083
[TBL] [Abstract][Full Text] [Related]
34. The third case of Doss porphyria (delta-amino-levulinic acid dehydratase deficiency) in Germany.
Doss MO; Stauch T; Gross U; Renz M; Akagi R; Doss-Frank M; Seelig HP; Sassa S
J Inherit Metab Dis; 2004; 27(4):529-36. PubMed ID: 15303011
[TBL] [Abstract][Full Text] [Related]
35. [Usefulness of delta-aminolevulinic acid in blood as an indicator of lead exposure].
Morita Y; Sakai T; Araki S; Araki T; Masuyama Y
Sangyo Igaku; 1993 Mar; 35(2):112-8. PubMed ID: 8510341
[TBL] [Abstract][Full Text] [Related]
36. Relationships between blood lead and indicators of effect in cows environmentally exposed to lead.
Telisman S; Prpić-Majić D; Kersanc A
Toxicol Lett; 1990 Aug; 52(3):347-56. PubMed ID: 2389263
[TBL] [Abstract][Full Text] [Related]
37. delta-Aminolevulinic acid dehydratase activity, urinary delta-aminolevulinic acid concentration and zinc protoporphyrin level among people with low level of lead exposure.
Wang Q; Zhao HH; Chen JW; Hao QL; Gu KD; Zhu YX; Zhou YK; Ye LX
Int J Hyg Environ Health; 2010 Jan; 213(1):52-8. PubMed ID: 19733117
[TBL] [Abstract][Full Text] [Related]
38. Determination of delta-aminolevulinic acid in plasma using high-performance liquid chromatography: a sensitive indicator of lead effects.
Morita Y; Araki S; Sakai T; Araki T; Masuyama Y
Ind Health; 1994; 32(2):85-96. PubMed ID: 7806449
[TBL] [Abstract][Full Text] [Related]
39. Effects of lead exposure on the activity of erythrocyte pyrimidine 5'-nucleotidase and delta-aminolevulinic acid dehydratase in mice.
Tomokuni K
Tohoku J Exp Med; 1983 Jan; 139(1):27-32. PubMed ID: 6301100
[No Abstract] [Full Text] [Related]
40. Relation between reticulocyte count and characteristics of erythrocyte 5'-nucleotidase in dogs, cats, cattle and humans.
Hossain MA; Yamato O; Yamasaki M; Otsuka Y; Maede Y
J Vet Med Sci; 2003 Feb; 65(2):193-7. PubMed ID: 12655113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]